Grigoryan Eleonora N
Kol'tsov Institute of Developmental Biology, Russian Academy of Sciences, 119334 Moscow, Russia.
Life (Basel). 2022 Mar 6;12(3):382. doi: 10.3390/life12030382.
Pigment epithelial cells (PECs) of the retina (RPE), ciliary body, and iris (IPE) are capable of altering their phenotype. The main pathway of phenotypic switching of eye PECs in vertebrates and humans in vivo and/or in vitro is neural/retinal. Besides, cells of amphibian IPE give rise to the lens and its derivatives, while mammalian and human RPE can be converted along the mesenchymal pathway. The PECs' capability of conversion in vivo underlies the lens and retinal regeneration in lower vertebrates and retinal diseases such as proliferative vitreoretinopathy and fibrosis in mammals and humans. The present review considers these processes studied in vitro and in vivo in animal models and in humans. The molecular basis of conversion strategies in PECs is elucidated. Being predetermined onto- and phylogenetically, it includes a species-specific molecular context, differential expression of transcription factors, signaling pathways, and epigenomic changes. The accumulated knowledge regarding the mechanisms of PECs phenotypic switching allows the development of approaches to specified conversion for many purposes: obtaining cells for transplantation, creating conditions to stimulate natural regeneration of the retina and the lens, blocking undesirable conversions associated with eye pathology, and finding molecular markers of pathology to be targets of therapy.
视网膜色素上皮细胞(RPE)、睫状体色素上皮细胞和虹膜色素上皮细胞(IPE)能够改变其表型。在体内和/或体外,脊椎动物和人类眼部色素上皮细胞表型转换的主要途径是神经/视网膜途径。此外,两栖动物IPE细胞可产生晶状体及其衍生物,而哺乳动物和人类的RPE可沿间充质途径转化。色素上皮细胞在体内的转化能力是低等脊椎动物晶状体和视网膜再生以及哺乳动物和人类视网膜疾病(如增殖性玻璃体视网膜病变和纤维化)的基础。本综述探讨了在动物模型和人类中体外和体内研究的这些过程。阐明了色素上皮细胞转化策略的分子基础。从个体发育和系统发育角度来看,这一基础包括物种特异性分子背景、转录因子的差异表达、信号通路和表观基因组变化。关于色素上皮细胞表型转换机制的积累知识有助于开发多种特定转化方法:获取用于移植的细胞、创造刺激视网膜和晶状体自然再生的条件、阻断与眼部病理相关的不良转化以及寻找作为治疗靶点的病理分子标志物。